are some leading players operating in the global atherectomy devices market landscape.
Authors:
Mariam Faizullabhoy , Shishanka Wangnoo
Frequently Asked Questions (FAQ) :
The market size of atherectomy devices was valued at USD 660 million in 2022 and is expected to register over 7% CAGR during 2023 to 2032 owing to the high patient preference for minimally invasive procedures.
The demand for orbital atherectomy devices amassed more than USD 204 million in 2022 and is anticipated to grow at steady pace through 2032 due to their increasing use in minimally invasive procedures for their several clinical benefits.
North America atherectomy devices industry is estimated to be worth USD 865 million by 2032 attributed to the presence of prominent market participants and the higher number of patients suffering from PAD.
Some of the renowned atherectomy devices manufacturers are include Medtronic plc, Avinger, Boston Scientific, Cardiovascular Systems, Inc., Koninklijke Philips N.V, Abbott Laboratories, AngioDynamics Inc., Becton, Dickinson and Company, Terumo Corporation, Cardinal Health Inc., Nipro Corporation, Biomerics LLC and Rex Medical